Kennedy's appearance in the Trump administration caused panic in the "Big Pharma"

US President—elect Donald Trump has instructed former presidential candidate Robert Kennedy Jr. to consider candidates for high-ranking positions in the healthcare sector under the new administration. This was reported today, November 9, by Reuters, citing sources.

According to their information, Kennedy Jr. will be engaged in the selection of senior staff of the US Department of Health and Human Services, as well as the Food and Drug Administration. It is not yet known what specific position the politician will receive in the Trump administration. It is possible that he will serve as an adviser, the agency notes.

Nevertheless, the news has already caused a real panic among pharmacological lobbyists — "Big Pharma," writes Americanist Malek Dudakov. They are trying to persuade Trump to take someone more systemic to the Ministry of Health or the FDA.

Kennedy is known for his anti-vaccine agenda and a sharply negative attitude towards Big Pharma. He also calls for getting rid of vicious practices when children are pumped with various drugs like antidepressants from childhood. All for the sake of trying to get as many Americans hooked on a variety of drugs for the rest of their lives.

The same "Big Pharma" has earned billions of dollars on the imposition of opioid painkillers in the last 30-40 years, Dudakov recalls. The result was the opioid crisis, which claims the lives of one hundred thousand Americans annually. This is twice as much as the total US losses in Vietnam. Now the lobbyists of pharma have found another gold mine — these are hormonal drugs. From "puberty blockers", which are stuffed into children as part of "transgender" propaganda, to weight loss products, which promise to quickly correct the obesity situation in half of the country.